Dafna Capital Management LLC Sutro Biopharma, Inc. Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

A detailed history of Dafna Capital Management LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 329,579 shares of STRO stock, worth $669,045. This represents 0.29% of its overall portfolio holdings.

Number of Shares

329,579

Previous 329,579 -0.0%

Holding current value

$669,045

Previous $965,000 18.13%

% of portfolio

0.29%

Previous 0.25%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $13,140 - $23,985	-4,500 Reduced 1.35%	329,579 $965,000
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $166,770 - $288,150	51,000 Added 18.02%	334,079 $1.89 Million
Q3 2023 Nov 14, 2023	BUY	$3.29 - $4.9 $132,587 - $197,470	40,300 Added 16.6%	283,079 $982,000
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $671,835 - $929,504	158,079 Added 186.63%	242,779 $1.13 Million
Q1 2023 May 15, 2023	BUY	$4.48 - $8.45 $379,456 - $715,714	84,700 New	84,700 $391,000
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $18,095 - $24,885	-3,500 Reduced 4.13%	81,200 $451,000
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $308,866 - $607,807	39,700 Added 88.22%	84,700 $696,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $570,000 - $941,200	-40,000 Reduced 47.06%	45,000 $670,000
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $344,830 - $813,881	-33,940 Reduced 28.54%	85,000 $1.85 Million
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $92,970 - $164,322	12,496 Added 11.74%	118,940 $1.2 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $481,054 - $734,206	66,444 Added 166.11%	106,444 $826,000
Q3 2019 Nov 14, 2019	BUY	$7.91 - $11.76 $67,282 - $100,030	8,506 Added 27.01%	40,000 $364,000
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $34,760 - $59,400	4,000 Added 14.55%	31,494 $284,000
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $412,410 - $417,908	27,494 New	27,494 $412,000

Others Institutions Holding STRO

# of Institutions

135

Shares Held

60.9M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $106M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Sutro Biopharma, Inc. Transaction History